Novel therapies to drive PD market across 7MM to $6.4 billion in 2029
A novel delivery system for levodopa is expected to offer a non-invasive route of administration, reduce pill burden and improve compliance.
Clinical Trials Analysis
Breast Cancer accounts for 12.2% share of global Oncology clinical trial activity in 2020
Lupus Erythematosus accounts for 8.2% share of global Immunology clinical trial activity in 2020
Schizophrenia accounts for 2.9% share of global Central Nervous System clinical trial activity in 2020
Depression accounts for 7.6% share of global Central Nervous System clinical trial activity in 2020
Pain accounts for 47.7% share of global Central Nervous System clinical trial activity in 2020
